Emraclidine's failure in phase 2 trials is a significant setback for AbbVie's neuroscience pipeline. This was a very ...

Calgary, Canada, is no stranger to water infrastructure issues, having recently experienced a mainline break and subsequent ...

Fletcher Building said the Western Australia Government, the New Zealand company’s subsidiary Iplex Pipelines Australia, and other stakeholders had finalised an agreement in response to pipe failures ...

Now, the pharma business is always a bit of a crap-shoot for novel drug therapies, but there could be some lingering market ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Wintertime is just around the corner here in eastern Iowa and as temperatures continue to cool off, that means more heat -- ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.

For AbbVie, the failure of a high-profile schizophrenia drug hardly marks its last chance to invest in neuroscience. But the ...

The shocking failure of AbbVie’s emraclidine has investors questioning the Big Pharma’s long-term neuroscience strategy, ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...

The agreement between Southwest Gas and the Commission's Office of Pipeline Safety resolves the two incidents ... other ...

(NYSEA:IBIO) today reported financial results for the fiscal first quarter ended September 30, 2024 and provided a corporate ...